Analysts: Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

119.45EUR
4:33am EDT
Price Change (% chg)

€0.45 (+0.38%)
Prev Close
€120.50
Open
€119.10
Day's High
€119.80
Day's Low
€119.10
Volume
21,452
Avg. Vol
258,939
52-wk High
€127.50
52-wk Low
€71.95

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month		 Last Updated
Hold 2.22 December 20 May 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago		 2 Month
Ago		 3 Month
Ago
(1) BUY 3 3 2 2
(2) OUTPERFORM 1 1 1 1
(3) HOLD 9 10 12 13
(4) UNDERPERFORM 5 4 5 5
(5) SELL 4 4 3 3
No Opinion 0 0 0 0
Mean Rating 3.27 3.23 3.26 3.25

Consensus Estimates Analysis

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-13 3 2,841.02 2,902.07 2,802.00 --
Quarter Ending Sep-13 3 2,789.02 2,882.07 2,721.00 --
Year Ending Dec-13 21 11,258.80 11,515.00 10,893.00 10,707.90
Year Ending Dec-14 20 11,383.70 11,770.00 10,983.00 10,886.20
Earnings (per share)
Quarter Ending Jun-13 3 2.22 2.32 2.14 --
Quarter Ending Sep-13 3 2.09 2.27 1.96 --
Year Ending Dec-13 22 8.39 9.10 5.32 7.68
Year Ending Dec-14 20 8.92 9.58 6.10 8.09
LT Growth Rate (%) 8 6.88 11.40 3.10 9.10

Historical Surprises

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 2,760.89 2,760.50 0.39 0.01
Quarter Ending Dec-12 2,772.06 2,712.10 59.96 2.16
Quarter Ending Sep-12 2,718.08 2,721.70 3.62 0.13
Quarter Ending Jun-12 2,645.17 2,852.10 206.93 7.82
Quarter Ending Mar-12 2,607.87 2,563.90 43.97 1.69
Earnings (per share)
Quarter Ending Mar-13 2.04 2.11 0.07 3.48
Quarter Ending Dec-12 2.03 2.05 0.02 0.80
Quarter Ending Sep-12 1.91 1.98 0.07 3.41
Quarter Ending Jun-12 1.79 1.92 0.13 7.07
Quarter Ending Mar-12 1.74 1.67 0.07 4.19

Consensus Estimates Trend

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  Current 1 Week
Ago		 1 Month
Ago		 2 Month
Ago		 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-13 2,841.02 2,825.54 2,831.30 -- --
Quarter Ending Sep-13 2,789.02 2,795.31 2,798.96 -- --
Year Ending Dec-13 11,258.80 11,281.90 11,272.20 11,273.10 10,707.90
Year Ending Dec-14 11,383.70 11,388.00 11,383.30 11,353.30 10,886.20
Earnings (per share)
Quarter Ending Jun-13 2.22 2.16 2.16 2.09 --
Quarter Ending Sep-13 2.09 2.12 2.19 2.39 --
Quarter Ending Dec-13 8.39 8.29 8.43 8.40 7.68
Quarter Ending Dec-14 8.92 8.83 8.97 8.98 8.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-13 1 2 1 1
Quarter Ending Sep-13 1 2 1 1
Year Ending Dec-13 2 7 4 8
Year Ending Dec-14 2 7 4 6
Earnings
Quarter Ending Jun-13 1 0 1 0
Quarter Ending Sep-13 0 2 0 2
Year Ending Dec-13 6 2 9 1
Year Ending Dec-14 5 2 7 1

Earnings vs. Estimates

» More Financials

Merck KGaA News

» More MRCG.DE News

Analyst Research Reports

Report Title Price
Merck KGaA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
ValuEngine Detailed Valuation Report for MKGAF
Provider: ValuEngine, Inc.
$127.00
Buy
Merck - Finlabo Research Equity Report: Fundamental and Technical Analysis and 6 months performance forecast
Provider: Finlabo SIM Spa
$58.00
Buy
Wright Investors Service Comprehensive Report for Merck KGaA
Provider: Wright Reports
$472.00
Buy
Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks